Mathew Njoroge Selected Research

Mathew Njoroge Research Topics

8	Malaria 01/2021 - 09/2015
3	Tuberculosis (Tuberculoses) 01/2022 - 12/2015
3	Infections 10/2020 - 12/2018
2	Parasitemia 01/2019 - 12/2013
1	Cardiotoxicity 01/2019
1	Extensively Drug-Resistant Tuberculosis 01/2019
1	Body Weight (Weight, Body) 03/2017
1	Schistosomiasis (Bilharziasis) 01/2017

2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	SulfonesIBA 10/2020 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2019
2	Antimalarials (Antimalarial Agents)IBA 12/2018 - 12/2018
2	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 12/2018 - 01/2018
1	octaneIBA 01/2021
1	Phosphotransferases (Kinase)IBA 11/2020
1	BenzimidazolesIBA 01/2019
1	Biological ProductsIBA 01/2019
1	EstersIBA 01/2019
1	Ether (Diethyl Ether)IBA 01/2019
1	Fusidic Acid (Fucithalmic)IBA 01/2019
1	TriterpenesIBA 01/2019
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	SilicatesIBA 01/2019
1	ProdrugsIBA 12/2018
1	Chloroquine (Aralen)FDA LinkGeneric 12/2018
1	sulfoxideIBA 12/2018
1	imidazopyridineIBA 10/2018
1	MMV390048IBA 01/2018
1	alpha-aminopyridineIBA 01/2018
1	aspalathinIBA 03/2017
1	Praziquantel (Biltricide)FDA Link 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 12/2015
1	CytochromesIBA 12/2015
1	Cytochromes c (Cytochrome c)IBA 12/2015
1	Amodiaquine (Camoquin)FDA Link 09/2015

2	Oral Administration 01/2019 - 12/2013